BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao Y, Hong F, Conlon DM, Sidur L, Smith KM, Fang Y, Cuff CA, Kaymakcalan Z, Ruzek MC. Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa. Br J Dermatol 2021. [PMID: 33811319 DOI: 10.1111/bjd.20097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gibson RS, Porter ML, Kimball AB. Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa. JAAD International 2022;8:47-8. [DOI: 10.1016/j.jdin.2022.04.005] [Reference Citation Analysis]
2 Rosi E, Fastame MT, Scandagli I, Di Cesare A, Ricceri F, Pimpinelli N, Prignano F. Insights into the Pathogenesis of HS and Therapeutical Approaches. Biomedicines 2021;9:1168. [PMID: 34572354 DOI: 10.3390/biomedicines9091168] [Reference Citation Analysis]
3 Batycka-Baran A, Matusiak Ł, Nowicka-Suszko D, Szepietowski JC, Baran W. Increased Serum Levels of S100A4 and S100A15 in Individuals Suffering from Hidradenitis Suppurativa. J Clin Med 2021;10:5320. [PMID: 34830597 DOI: 10.3390/jcm10225320] [Reference Citation Analysis]
4 Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells 2021;10:2094. [PMID: 34440863 DOI: 10.3390/cells10082094] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Frew JW. Therapeutic biomarkers in hidradenitis suppurativa: one step closer to the clinic. Br J Dermatol 2021. [PMID: 34131898 DOI: 10.1111/bjd.20513] [Reference Citation Analysis]
6 Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis 2021;12:20406223211055920. [PMID: 34840709 DOI: 10.1177/20406223211055920] [Reference Citation Analysis]
7 Pinter A, Mrowietz U, Volz T. [Systemic treatment of moderate/severe hidradenitis suppurativa]. Hautarzt 2021;72:686-91. [PMID: 34189590 DOI: 10.1007/s00105-021-04844-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]